Combining rivaroxaban with aspirin for peripheral artery disease: an in-depth systematic review and meta-analysis

8 March 2024 (08:30 - 13:45)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Billy Joseph David

St Lukes Medical Center Global City, Global City (Philippines)

6 More presentations in this session

Presentation thumbnail

Cardiac rehabilitation makes a difference: lipid control targets and prognosis.

Mrs M. Lucas Garcia (Sevilla, Spain, ES)

Abstract Slides

Presentation thumbnail

The lipid profile of the young patient with ischemic heart disease. Do these patients meet the goals?

Doctor M. Pelaz Sanchez (Seville, ES)

Abstract Slides

Presentation thumbnail

Prescription of lipid-lowering therapy, LDLc control, and risk of MACE in patients after ST-elevation myocardial infarction in Mexico

Miss S. Hernandez Pastrana (Mexico City, MX)

Abstract Slides

Presentation thumbnail

Risk factors for intensive care admission in pediatric patients with COVID-19 - results of the German na-tionwide inpatient sample

Doctor K. Keller (Mainz, DE)

Abstract Slides

Presentation thumbnail

P2Y12 monotherapy versus standard dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and meta-analysis

Doctor B. Buot (Quezon City, PH)

Abstract Slides

Access the full session

Session thumbnail

Risk factors, prevention, and pharmacotherapy

The Event

Event poster

ESC Acute CardioVascular Care 2024

8 March - 10 March 2024

You may be interested in

Congress Presentation

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

Congress Presentation

State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources